Billings Clinic
Especially For:

Clinical Trials

Title   Type 2 Diabetes (ITCA 105)
Description   A phase 3, randomized, active comparator, double-blind, multi center study to compare the efficacy, safety and tolerability of ITCA 650 to Sitagliptin as Add-on therapy to metformin in patients with Type 2 Diabetes
IRB Number   ITCA 650-CLP-105
Category   Diabetes
Inclusion/Notes   You may be able to take part if you:

* are between 18 and 80 years of age
* have been diagnosed with type 2 diabetes for more than 3 months.

Investigational product, examinations, and medical care relating to the study will be provided at no cost to you.
Status   Currently Recruiting
Start Date   05/28/2013
Principal Investigator (PI)   Christopher Sorli, MD
Physician Profile   Christopher Sorli MD
Contact Name   Recruitment Nurse
Contact Email   Marilyn Lindell
Phone   (406) 657-4111
Alternate Phone   (800) 996-2663
Fax   (406) 247-6512
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.